AngioGenex, Inc. (AGGX) news stock charts
AngioGenex, Inc. (AGGX/AGGX.OB) Investment Summary:
AngioGenex, Inc., a biopharmaceutical company, engages in the discovery, acquisition, and development of products for the treatment, diagnosis, and prognosis of cancer. Its development programs focus on the discovery and development of orally active anti-cancer drugs that act by modulating the action of the Id proteins; the measurement of Id proteins in tumors and blood to create products for the diagnosis and prognosis of cancer; the generation of proof-of-concept data in relevant preclinical models to establish that modulation of Id genes and proteins is useful to treat non-oncologic diseases; and collaborating in respect to treatments of diseases in which blood vessel proliferation is des...www.angiogenex.com
Founded in 1999
ANGIOGENEX INC (AGGX:OTC Bulletin Board Market)
LAST $0.08 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of 8:10 PM 03/2/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of ANGIOGENEX INC (AGGX)
|
OPEN
$0.08
|
PREVIOUS CLOSE
$0.08
|
|
|
DAY HIGH
$0.08
|
DAY LOW
$0.08
|
|
|
52 WEEK HIGH
09/1/09 - $0.35
|
52 WEEK LOW
01/29/10 - $0.04
|
|
|
MARKET CAP
1.7M
|
AVERAGE VOLUME 10 D
0.0
|
|
|
EPS TTM
--
|
SHARES OUTSTANDING
21.3M
|
|
|
AGGX Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for ANGIOGENEX INC (AGGX)
AngioGenex Inc., Annual General Meeting, Dec 31, 2009
12/4/2009
AngioGenex Inc., Annual General Meeting, Dec 31, 2009, at 14:00 US Eastern Time. Location: 425 Madison Avenue, Suite 902, New York, NY 10017,United States. Agenda: To elect a Board of four (4) directors, to serve until the 2009 annual meeting of stockholders or until their successors are duly elected and qualified; to ratify the appointment of LI & COMPANY, PC as its independent auditors for the year ending December 31, 2009; and to transact such other business as may properly come before the Annual Meeting or at any adjournments or postponements thereof.
AngioGenex, Inc. announced delayed 10-Q filing
11/16/2009
On 11/16/2009, AngioGenex, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
AngioGenex, Inc. announced delayed 10-Q filing
08/17/2009
On 08/17/2009, AngioGenex, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
AngioGenex, Inc. financial resources
AGGX Competitors
| Company | Last | Change | |
| No competitor information is available for AGGX. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | AGGX | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | -- | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
AGGX |
||
AGGX transactions
| Type Date |
Target |
|
Private Placement
November 16, 2009 |
-- |
More Recent Financial News About AngioGenex, Inc.
ANGIOGENEX, INC. Files SEC form 8-K, Financial Statements and Exhibits
2009-11-27 23:55:10
Quote: ANGIOGENEX, INC.Request a Trial to NEW EDGAR Online Pro
Form
8-K for
ANGIOGENEX, INC.
12-May-2009Financial Statements and ExhibitsPrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, o...Read article
ANGIOGENEX, INC. Files SEC form 8-K, Financial Statements and Exhibits
2009-11-27 23:55:10
Quote: ANGIOGENEX, INC.Request a Trial to NEW EDGAR Online Pro
Form
8-K for
ANGIOGENEX, INC.
5-May-2009Financial Statements and ExhibitsPrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, or...Read article
ANGIOGENEX, INC. Files SEC form 10-K, Annual Report
2009-11-27 23:55:10
Quote: ANGIOGENEX, INC.Request a Trial to NEW EDGAR Online Pro
Form
10-K for
ANGIOGENEX, INC.
14-Apr-2009Annual ReportPrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, or for any actions t...Read article
ANGIOGENEX, INC. Files SEC form 8-K, Financial Statements and Exhibits
2009-11-27 23:55:10
Quote: ANGIOGENEX, INC.Request a Trial to NEW EDGAR Online Pro
Form
8-K for
ANGIOGENEX, INC.
26-Nov-2008Financial Statements and ExhibitsPrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, o...Read article
Would you like to leave a comment about AngioGenex, Inc. AGGX/AGGX.OB
Find out what social network information about AngioGenex, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides AngioGenex, Inc.'s Stock there is more great penny stock and market information at Realpennies